A carregar...
Identification of Candidate Biomarkers for EGFR-T790M Drug-resistant Gene Mutation in Advanced Lung Adenocarcinoma
Background and objective Osimertinib is approved by Food and Drug Administration for patients with advanced non-small cell lung cancer carrying EGFR-T790M mutations. Osimertinib therapy was missed in many patients who were unable to perform biopsy due to occult lesion progression or weak body. In th...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2020-11-01
|
| Colecção: | Chinese Journal of Lung Cancer |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.104.20 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|